Health Care Hotspotting: A Randomized Controlled Trial of the Link2Care Program

A randomized controlled trial led by Amy Finkelstein of MIT investigates the Camden Coalition's Link2Care program. The study targets 'super-utilizers'—adults with 2+ hospitalizations and 2+ chronic conditions in the prior six months—to measure the impact of intensive care management on subsequent hospital use. The intervention involves a multidisciplinary team using real-time data to provide home visits and social-service navigation support.

Use Cases

• Evaluate the impact of intensive care management on hospital readmission rates based on the randomized trial design.
• Analyze healthcare utilization patterns for 'super-utilizer' patients based on the described eligibility criteria.
• Model the cost-effectiveness of multidisciplinary team interventions based on the program's described structure and goals.

Strengths

• Data originates from a randomized controlled trial, a gold-standard method for causal inference.
• The intervention is described in detail, involving a team of nurses, social workers, and community health workers.
• The target population is precisely defined as adults with 2+ hospitalizations and 2+ chronic conditions in a six-month period.

Limitations

• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for specific modeling tasks.
• Last update date is unknown; freshness unverified.

Provenance

Source

Amy Finkelstein, Massachusetts Institute of Technology

Collection Method

Randomized controlled trial of the Camden Coalition of Healthcare Providers' Link2Care program.

Time Range

null

Freshness

Last updated: unknown

Geography

null